Harnessing Metal Homeostasis Offers Novel and Promising Targets Against Candida albicans.


Journal

Current drug discovery technologies
ISSN: 1875-6220
Titre abrégé: Curr Drug Discov Technol
Pays: United Arab Emirates
ID NLM: 101157212

Informations de publication

Date de publication:
2020
Historique:
received: 03 08 2018
revised: 08 01 2019
accepted: 30 01 2019
pubmed: 5 3 2019
medline: 21 9 2021
entrez: 5 3 2019
Statut: ppublish

Résumé

Fungal infections, particularly of Candida species, which are the commensal organisms of human, are one of the major debilitating diseases in immunocompromised patients. The limited number of antifungal drugs available to treat Candida infections, with the concomitant increasing incidence of multidrug-resistant (MDR) strains, further worsens the therapeutic options. Thus, there is an urgent need for the better understanding of MDR mechanisms, and their reversal, by employing new strategies to increase the efficacy and safety profiles of currently used therapies against the most prevalent human fungal pathogen, Candida albicans. Micronutrient availability during C. albicans infection is regarded as a critical factor that influences the progression and magnitude of the disease. Intracellular pathogens colonize a variety of anatomical locations that are likely to be scarce in micronutrients, as a defense strategy adopted by the host, known as nutritional immunity. Indispensable critical micronutrients are required both by the host and by C. albicans, especially as a cofactor in important metabolic functions. Since these micronutrients are not freely available, C. albicans need to exploit host reservoirs to adapt within the host for survival. The ability of pathogenic organisms, including C. albicans, to sense and adapt to limited micronutrients in the hostile environment is essential for survival and confers the basis of its success as a pathogen. This review describes that micronutrients availability to C. albicans is a key attribute that may be exploited when one considers designing strategies aimed at disrupting MDR in this pathogenic fungi. Here, we discuss recent advances that have been made in our understanding of fungal micronutrient acquisition and explore the probable pathways that may be utilized as targets.

Identifiants

pubmed: 30827249
pii: CDDT-EPUB-96922
doi: 10.2174/1570163816666190227231437
doi:

Substances chimiques

Antifungal Agents 0
Metals 0
Micronutrients 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-429

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Saif Hameed (S)

Amity Institute of Biotechnology, Amity University Haryana, Gurugram (Manesar)-122413, India.

Sandeep Hans (S)

Amity Institute of Biotechnology, Amity University Haryana, Gurugram (Manesar)-122413, India.

Shweta Singh (S)

Amity Institute of Biotechnology, Amity University Haryana, Gurugram (Manesar)-122413, India.

Zeeshan Fatima (Z)

Amity Institute of Biotechnology, Amity University Haryana, Gurugram (Manesar)-122413, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH